Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses the unmet needs that still exist for patients with pain.
Wayne Jonas, MD, executive director of Samueli Integrative Health Programs at H&S Ventures, discusses the unmet needs that still exist for patients with pain.
Transcript
What are some of the unmet needs for patients with chronic and acute pain?
I would say the main unmet need that we have in the management of chronic pain is the failure to take into account the whole person. People with chronic pain do not just have a problem in the area that the pain has manifested in their body, but affects them as entire people. It affects their psychology, sometimes precipitating or aggravating mental health conditions. It can affect their sleep, which then affects multiple other things. It can affect their social life so that they can't actually go out and participate in activities or even care for their families, for example. And it even affects their souls. Some people give up. They say, "What's the purpose of trying to live my life in joy if I'm in chronic pain?"
So, the basic unmet need is to take care of the whole person, listen to the whole person, and address all their needs. Mental health, behavioral health and psychological approaches should be part of all chronic pain management. Sleep, for example, is often overlooked and yet is a key part of chronic pain management.
I think the second major unmet need is a lack of knowledge and skills for nondrug approaches. The evidence has now accumulated that there are many nondrug approaches available and effective for chronic pain and we need to have these tools in our toolbox, as providers, to meet those needs.
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurativa (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More